Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...

Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

Policymakers at the federal and state level have considered a number of reforms, many of which have bipartisan support, to ...

KLOXXADO ® delivers 8 mg of naloxone hydrochloride per spray in a ready to use nasal spray to reverse the effects of opioid overdose.

CMS should monitor the effect on Medicare standalone prescription drug plans of changes in how the drug costs of high-cost ...

Cash Position & Operating Runway: As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments ...

Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and ...

LucyRx, a next-generation pharmacy benefit management company, has launched the Sustaining Pharmacy Access & Rural Care ...

Stay updated on market trends for UNH. Vertex Newly Approved Pain Treatment Lands Higher Cost Tier 3 Placement In UnitedHealth's Optum Rx Formularies Vertex's Journavx, a new non-opioid pain drug ...

As health complications and deaths from alcohol use disorder (AUD) increase in the United States, it is critical that people ...

The small Winnipeg biotechnology company focused on technologies and products that prevent and remove microbial biofilms just signed its first Canadian distribution deal for its antimicrobial wound ...